Enovis (ENOV) Net Equity Issued and Repurchased (2011 - 2026)

Enovis' (ENOV) quarterly Net Equity Issued and Repurchased came in at $628000.0 in Q2 2026, up 84.16% year-on-year from $341000.0 in Q2 2025, and up 232.28% on a QoQ basis from $189000.0 in Q4 2025.

Enovis (ENOV) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends

Enovis (ENOV) has 16 years of Net Equity Issued and Repurchased data on file, last reported at $628000.0 in Q2 2026.

  • On a quarterly basis, Net Equity Issued and Repurchased rose 84.16% year-over-year to $628000.0 in Q2 2026; TTM through Apr 2026 was $1.6 million, a 19.42% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, down 29.67% from the prior year.
  • Net Equity Issued and Repurchased for Q2 2026 stood at $628000.0, up from $189000.0 in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for ENOV reached as high as $3.3 million in Q4 2022 and fell as low as $104000.0 in Q3 2023.
  • Historically, Net Equity Issued and Repurchased has averaged $713125.0 across 5 years, with a median of $483000.0 in 2022.
  • Across the five-year window, Net Equity Issued and Repurchased sank 99.83% in 2022 and surged 263.46% in 2024, its largest moves.
  • Year by year, Net Equity Issued and Repurchased stood at $3.3 million in 2022, then sank by 91.26% to $287000.0 in 2023, then rose by 11.15% to $319000.0 in 2024, then sank by 40.75% to $189000.0 in 2025, then soared by 232.28% to $628000.0 in 2026.
  • Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $628000.0 in Q2 2026, $189000.0 in Q4 2025, and $788000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Enovis 1.50 Bn 1.47 Bn 365.49 Mn 628,000.00

Historic Data

Download Data
DateValue
Apr 3, 2026 628,000.00
Apr 3, 2026 628,000.00
Oct 3, 2025 189,000.00
Oct 3, 2025 189,000.00
Jul 4, 2025 788,000.00
Jul 4, 2025 788,000.00
Apr 4, 2025 341,000.00
Apr 4, 2025 341,000.00
Dec 31, 2024 319,000.00
Dec 31, 2024 319,000.00
Sep 27, 2024 378,000.00
Sep 27, 2024 378,000.00
Jun 28, 2024 306,000.00
Jun 28, 2024 306,000.00
Mar 29, 2024 871,000.00
Mar 29, 2024 871,000.00
Dec 31, 2023 287,000.00
Dec 31, 2023 287,000.00
Sep 29, 2023 104,000.00
Sep 29, 2023 104,000.00